Skip to main content
Kent Academic Repository

Recovery of current through mutated TASK3 potassium channels underlying Birk Barel syndrome.

Veale, Emma L., Hassan, Mustafa, Walsh, Yvonne, Al-Moubarak, Ehab, Mathie, Alistair (2014) Recovery of current through mutated TASK3 potassium channels underlying Birk Barel syndrome. Molecular pharmacology, 85 (3). pp. 397-407. ISSN 1521-0111. (doi:10.1124/mol.113.090530) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:75884)

PDF Publisher pdf
Language: English

Restricted to Repository staff only
[thumbnail of Veale et al., 2014 Birk Barel.pdf]
Official URL:


TASK3 (TWIK-related acid-sensitive K(+) channel 3) potassium channels are members of the two-pore-domain potassium channel family. They are responsible for background leak potassium currents found in many cell types. TASK3 channels are genetically imprinted, and a mutation in TASK3 (G236R) is responsible for Birk Barel mental retardation dysmorphism syndrome, a maternally transmitted developmental disorder. This syndrome may arise from a neuronal migration defect during development caused by dysfunctional TASK3 channels. Through the use of whole-cell electrophysiologic recordings, we have found that, although G236R mutated TASK3 channels give rise to a functional current, this current is significantly smaller in an outward direction when compared with wild-type (WT) TASK3 channels. In contrast to WT TASK3 channels, the current is inwardly rectifying. Furthermore, the current through mutated channels is differentially sensitive to a number of regulators, such as extracellular acidification, extracellular zinc, and activation of Gαq-coupled muscarinic (M3) receptors, compared with WT TASK3 channels. The reduced outward current through mutated TASK3_G236R channels can be overcome, at least in part, by both a gain-of-function additional mutation of TASK3 channels (A237T) or by application of the nonsteroidal anti-inflammatory drug flufenamic acid (FFA; 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid). FFA produces a significantly greater enhancement of current through mutated channels than through WT TASK3 channels. We propose that pharmacologic enhancement of mutated TASK3 channel current during development may, therefore, provide a potentially useful therapeutic strategy in the treatment of Birk Barel syndrome.

Item Type: Article
DOI/Identification number: 10.1124/mol.113.090530
Subjects: R Medicine
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Emma Veale
Date Deposited: 19 Aug 2019 21:52 UTC
Last Modified: 17 Aug 2022 11:02 UTC
Resource URI: (The current URI for this page, for reference purposes)

University of Kent Author Information

Veale, Emma L..

Creator's ORCID:
CReDIT Contributor Roles:

Walsh, Yvonne.

Creator's ORCID:
CReDIT Contributor Roles:

Mathie, Alistair.

Creator's ORCID:
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.